These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 721708)
1. Early intermediates in the biosynthesis of ansamycins. I. Isolation and identification of protorifamycin I. Ghisalba O; Traxler P; Nüesch J J Antibiot (Tokyo); 1978 Nov; 31(11):1124-31. PubMed ID: 721708 [TBL] [Abstract][Full Text] [Related]
2. Early intermediates in the biosynthesis of ansamycins. III. Isolation and identification of further 8-deoxyansamycins of the rifamycin-type. Ghisalba O; Traxler P; Fuhrer H; Richter WJ J Antibiot (Tokyo); 1980 Aug; 33(8):847-56. PubMed ID: 7000738 [TBL] [Abstract][Full Text] [Related]
3. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. III. Isolation and identification of an early aromatic ansamycin-precursor containing the seven-carbon amino starter-unit and three initial acetate/propionate-units of the ansa chain. Ghisalba O; Fuhrer H; Richter WJ; Moss S J Antibiot (Tokyo); 1981 Jan; 34(1):58-63. PubMed ID: 7251510 [TBL] [Abstract][Full Text] [Related]
4. Ansamycin biogenesis: studies on a novel rifamycin isolated from a mutant strain of Nocardia mediterranei. White RJ; Martinelli E; Lancini G Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3260-4. PubMed ID: 4528428 [TBL] [Abstract][Full Text] [Related]
5. 3-Hydroxyrifamycin S and further novel ansamycins from a recombinant strain R-21 of Nocardia mediterranei. Traxler P; Schupp T; Fuhrer H; Richter WJ J Antibiot (Tokyo); 1981 Aug; 34(8):971-9. PubMed ID: 7319930 [TBL] [Abstract][Full Text] [Related]
6. New rifamycins produced by a recombinant strain of Nocardia mediterranei. Schupp T; Traxler P; Auden JA J Antibiot (Tokyo); 1981 Aug; 34(8):965-70. PubMed ID: 7319929 [TBL] [Abstract][Full Text] [Related]
7. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. I. Isolation and characterization of a pentose-excreting auxotrophic mutant of Nocardia mediterranei with drastically reduced rifamycin production. Ghisalba O; Nüesch J J Antibiot (Tokyo); 1978 Mar; 31(3):202-14. PubMed ID: 649515 [TBL] [Abstract][Full Text] [Related]
8. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. II. Isolation and characterization of a shikimate excreting auxotrophic mutant of Nocardia mediterranei with normal rifamycin-production. Ghisalba O; Nüesch J J Antibiot (Tokyo); 1978 Mar; 31(3):215-25. PubMed ID: 649516 [TBL] [Abstract][Full Text] [Related]
9. Early intermediates in the biosynthesis of ansamycins. II. Isolation and identification of proansamycin B-M1 and protorifamycin i-M1. Ghisalba O; Traxler P; Fuhrer H; Richter WJ J Antibiot (Tokyo); 1979 Dec; 32(12):1267-72. PubMed ID: 396289 [TBL] [Abstract][Full Text] [Related]
10. Rifamycin Z, a novel ansamycin from a mutant of Nocardia mediterranea. Cricchio R; Antonini P; Ferrari P; Ripamonti A; Tuan G; Martinelli E J Antibiot (Tokyo); 1981 Oct; 34(10):1257-60. PubMed ID: 7309622 [No Abstract] [Full Text] [Related]
11. Rifamycin R, a novel metabolite from a mutant of Nocardia mediterranea. Martinelli E; Antonini P; Cricchio R; Lancini G; White RJ J Antibiot (Tokyo); 1978 Oct; 31(10):949-51. PubMed ID: 711618 [TBL] [Abstract][Full Text] [Related]
12. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. IV. Identification of 3-amino-5-hydroxybenzoic acid as a direct precursor of the seven-carbon amino starter-unit. Ghisalba O; Nüesch J J Antibiot (Tokyo); 1981 Jan; 34(1):64-71. PubMed ID: 7251511 [TBL] [Abstract][Full Text] [Related]
13. 16,17-dihdrorifamycin S and 16,17-dihydro-17-hydroxyrifamycin S. Two novel rifamycins from a recombinant strain C 5/42 of Nocardia mediterranei. Traxler P; Schupp T; Wehrli W J Antibiot (Tokyo); 1982 May; 35(5):594-601. PubMed ID: 7107523 [No Abstract] [Full Text] [Related]
14. Rifamycin G, a further product of Nocardia mediterranei metabolism. Lancini G; Sartori G J Antibiot (Tokyo); 1976 Apr; 29(4):466-8. PubMed ID: 931815 [No Abstract] [Full Text] [Related]
15. Thiazorifamycins. III. Biosynthesis of rifamycins P, Q and verde, novel metabolites from a mutant of Nocardia mediterranea. Cricchio R; Antonini P; Sartori G J Antibiot (Tokyo); 1980 Aug; 33(8):842-6. PubMed ID: 7429988 [TBL] [Abstract][Full Text] [Related]
16. Study to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. Gygax D; Ghisalba O; Treichler H; Nüesch J J Antibiot (Tokyo); 1990 Mar; 43(3):324-6. PubMed ID: 2324014 [No Abstract] [Full Text] [Related]
17. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. V. Studies on the biogenetic origin of 3-substituents. Traxler P; Ghisalba O J Antibiot (Tokyo); 1982 Oct; 35(10):1361-6. PubMed ID: 7174520 [No Abstract] [Full Text] [Related]
18. B-factor, an essential regulatory substance inducing the production of rifamycin in a Nocardia sp. Kawaguchi T; Asahi T; Satoh T; Uozumi T; Beppu T J Antibiot (Tokyo); 1984 Dec; 37(12):1587-95. PubMed ID: 6526727 [TBL] [Abstract][Full Text] [Related]
19. Isolation of 11,12- seco-Rifamycin W Derivatives Reveals a Cleavage Pattern of the Rifamycin Ansa Chain. Shi Y; Zhang J; Tian X; Wu X; Li T; Lu C; Shen Y Org Lett; 2019 Feb; 21(4):900-903. PubMed ID: 30714736 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of some derivatives of rifamycin P. Cavalleri B; Turconi M; Tamborini G; Occelli E; Cietto G; Pallanza R; Scotti R; Berti M; Romanó G; Parenti F J Med Chem; 1990 May; 33(5):1470-6. PubMed ID: 2329569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]